Company: CXDO
Filing Date: 2025-03-04
Form Type: 10-K
Source: 0001654954-25-002287
Chunk: 411

Company: Crexendo, Inc.
Filing Date: 2025-03-04
Form: 10-K
Item: Item 2
Chunk 411
---
DA are calculated as follows for the periods presented.

Reconciliation of Non-GAAP Financial Measures

In accordance with the requirements of Regulation G issued by the SEC, we are presenting the most directly comparable U.S. GAAP financial measures and reconciling the unaudited Non-GAAP financial metrics to the comparable U.S. GAAP measures.

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income

(Unaudited, in thousands, except per share and share data)

  Three Months Ended December 31,  Year Ended December 31,   2024  2023  2024  2023   (In thousands)  (In thousands) U.S. GAAP net income/(loss) $507  $61  $1,677  $(362)Share-based compensation  709   737   3,002   3,849 Acquisition related expenses  -   -   -   1 Amortization of intangible assets  755   792   3,028   3,169 Non-GAAP net income $1,971  $1,590  $7,707  $6,657                  Non-GAAP earnings per common share:                Basic $0.07  $0.06  $0.29  $0.26 Diluted $0.06  $0.06  $0.26  $0.24                  Weighted-average common shares outstanding:                Basic  27,195,382   26,072,529   26,757,242   25,944,748 Diluted  30,547,245   28,314,527   30,019,359   27,792,813 

 33Table of Contents

Reconciliation of U.S. GAAP Net Income to EBITDA to Adjusted EBITDA

(Unaudited, in thousands)

  Three Months Ended December 31,  Year Ended December 31,   2024  2023  2024  2023   (In thousands)  (In thousands) U.S. GAAP net income/(loss) $507  $61  $1,677  $(362)Depreciation